Ifp Advisors, Inc Curis Inc Transaction History

Ifp Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.71 - $2.43 $71 - $243	100 New	100 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.71 - $2.43 $71 - $243	-100 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$2.31 - $5.13 $231 - $513	100 New	100 $0
Q3 2021 Oct 06, 2021	SELL	$6.94 - $8.85 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$7.45 - $16.27 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$8.78 - $12.8 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$1.08 - $8.2 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$0.95 - $1.42 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$0.63 - $1.7 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$0.67 - $1.85 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$1.36 - $2.44 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$1.74 - $2.83 $0 - $0	0 New	0 $0

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.